Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Sep 18;12(9):e0184852. doi: 10.1371/journal.pone.0184852

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Kawakubo et al

This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Fig 6 — (A) proportion of CD8⁺ T lymphocytes compared with CD3⁺ T lymphocytes in the tumor. (B) representative images of flow cytometry for CD8⁺ T lymphocytes on day 5 after aFP in the control group and aFP group respectively. The number in the figures represents proportion of CD8⁺ T lymphocytes compared with CD3⁺ T lymphocytes. (C and D) proportion of Treg compared with CD3 and CD4⁺ T lymphocytes in the tumor respectively. (E) representative images of flow cytometry for Treg on day 5 after aFP in the control group and aFP group respectively. The number in the figures represents proportion of CD4⁺ Foxp3⁺ Treg compared with CD4⁺ T lymphocytes. (F) proportion of beta-gal epitope specific CD8⁺ T lymphocytes compared with total CD8⁺ T lymphocytes in the tumor. (G) proportion of CD8⁺ T lymphocytes compared with Treg in the tumor.